Fulltext present in this item

Thumbnail
Fulltext: 179762.pdf
Format: PDF
Description: publisher's version
Title: Transcranial magnetic stimulation for schizophrenia: Potential and risks
Author(s): Bosch, M.P.C. ; Yeo, S.; Staudte, H.; Barisch, P.; Lim, S.; Noort, M.W.M.L. van den
Publication year: 2017
Source: Neuroimmunology and Neuroinflammation, vol. 4, iss. 12, (2017), pp. 258-259
Number of Pages: 2 p.
ISSN: 2347-8659
DOI: https://doi.org/10.20517/2347-8659.2017.48
Publication type: Article / Letter to editor

Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/179762   https://hdl.handle.net/2066/179762

Display more details
Subject: DI-BCB_DCC_Theme 3: Plasticity and Memory
Neuropsychology and rehabilitation psychology
Neuro- en revalidatiepsychologie
Organization: SW OZ DCC NRP
Journal title:
Neuroimmunology and Neuroinflammation
Volume: vol. 4
Issue: iss. 12
Page start: p. 258
Page end: p. 259
Abstract:
Recently, transcranial magnetic stimulation (TMS) has increasingly been used to investigate the neurobiology of schizophrenia. In those studies, researchers applied TMS in combination with motor evoked potentials (TMS/MEPs) and high density electroencephalograms (TMS/hd-EEG)[1]. The studies revealed significant impairments in cortical excitability, inhibition, and oscillatory activity, which are more prominent in the frontal brain areas, in patients suffering from schizophrenia compared to healthy controls[1]. Future TMS studies may help explain the underlying neurobiology of schizophrenia, and TMS may help monitor and perhaps further optimize the effectiveness of treatment interventions in patients with this disease. However, despite the potential of using TMS in the investigation of the underlying neurobiology of schizophrenia, three critical notes are essential.
Languages used: English (eng)

This item appears in the following Collection(s)

Browse

Statistics